Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado

Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study

Publicado 2020-06-03


https://doi.org/10.30554/archmed.20.2.3743.2020
##galleys.btn##
PDF (Espanhol) FLIP HTML (Espanhol) EPUB (Espanhol) PDF (Marcado) (Espanhol) FLIP EPUB (Marcado) (Espanhol) XML (Espanhol)
Edição
v. 20 n. 2 (2020):
Seção
Artículos de Investigación
Como Citar
Espitia de la Hoz, F. J. . (2020). Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado: Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study. Archivos De Medicina , 20(2), 282-294. https://doi.org/10.30554/archmed.20.2.3743.2020
Baixar Citação
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.20.2.3743.2020
Dimensions
PlumX

Como Citar

Espitia de la Hoz, F. J. . (2020). Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado: Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study. Archivos De Medicina , 20(2), 282-294. https://doi.org/10.30554/archmed.20.2.3743.2020

Baixar Citação

##articleSummary.license##
Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Franklin José Espitia de la Hoz
Director Científico Hathor, Clínica Sexológica. Armenia, Quindío,
https://orcid.org/0000-0002-4581-9680 ORCID
##submission.authorBio##

Franklin José Espitia de la Hoz,

Especialista Ginecología y Obstetricia, Universidad Militar Nueva Granada. Uroginecología y cirugía reconstructiva del piso pélvico / UNal, FUCS, Unicamp (Brasil). Máster en Sexología: Educación y asesoramiento sexual, Universidad de Alcalá de Henares. Fellow of the American College of Ginecology and Obstetric. Vicepresidente de la Asociación Colombiana de Menopausia. Director Científico Hathor, Clínica Sexológica. Armenia, Quindío, Colombia.

.

Visão geral 2302 | Visualizações de PDF 117

Downloads

Os dados de download ainda não estão disponíveis.
  1. Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. J Sex Med 2014; 11(12):2865-2872. DOI: https://doi.org/10.1111/jsm.12686
  2. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016; 215(6):704-711. DOI: https://doi.org/10.1016/j.ajog.2016.07.045
  3. Espitia-De la Hoz FJ. Prevalence of genitourinary syndrome of menopause and impact on sexuality of women in Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol 2018; 69(4):249-59. DOI: https://doi.org/10.18597/rcog.3111
  4. Mac-Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010; 85(1):87-94. DOI: https://doi.org/10.4065/mcp.2009.0413
  5. Espitia-De La Hoz FJ, Orozco-Gallego H. Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol Obstet Mex 2018; 86(2):117-126. DOI: https://doi.org/10.24245/gom.v86i2.1881
  6. Espitia-De La Hoz FJ, Orozco-Gallego H. Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización. Rev Med UCR 2017; 11(2):67-84. DOI: https://doi.org/10.15517/rmucr.v11i2.34580
  7. Coelingh-Bennink HJ. Are all estrogens the same? Maturitas 2004; 47(4):269-275. DOI: https://doi.org/10.1016/j.maturitas.2003.11.009
  8. Espitia-De La Hoz FJ, Orozco-Gallego H. Evaluación de la eficacia de dos terapias estrogénicas locales más un lubricante vaginal, para el control de los síntomas del síndrome genitourinario de la menopausia. Rev. Investigaciones Andina 2019; 38(21):167-183. DOI: https://doi.org/10.33132/01248146.998
  9. Espitia-De La Hoz FJ, Orozco-Gallego H, Echeverri-Ocampo LM. Terapia hormonal y no hormonal en la vaginitis atrófica posmenopáusica: curay satisfacción a mediano y a largo plazo de los síntomas. Rev Col de Menopausia 2016; 22(1):8-17.
  10. Espitia-De La Hoz FJ. Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause. Int J Fam Commun Med 2019; 3(3):132-136. DOI: https://doi.org/10.15406/ijfcm.2019.03.00145
  11. Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med 2010; 7(3):1139-1146. DOI: https://doi.org/10.1111/j.1743-6109.2009.01635.x
  12. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26(2):191-208. DOI: https://doi.org/10.1080/009262300278597
  13. Espitia- De La Hoz FJ. Dispositivo EROS en el manejo de la anorgasmia femenina: Estudio prospectivo de serie de casos en mujeres del Quindío. Univ Salud 2019; 21(1):38-47. DOI: http://dx.doi.org/10.22267/rus.192101.138
  14. Lee Y, Lim MC, Joo J, Park K, Lee S, Seo S, et al. Development and validation of the Korean version of the Female Sexual Function Index-6 (FSFI-6K). Yonsei Med J 2014; 55(5):1442-1446. DOI: https://doi.org/10.3349/ymj.2014.55.5.1442
  15. Bachmann GA, Notelovitz M, Kelly SJ, Thompson C, Owens A. Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sexuality 1992; 8:3-8.
  16. Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas 1995; Suppl(1):S1–S5. DOI: https://doi.org/10.1016/0378-5122(95)00956-6
  17. Patetico AQ, Reyes LD, Rey-Matias CJ. Comparison of the operative and post operative outcome between episiorrhaphy with and without application of policresulen solution. PJOG. 2016; 40(2):12-19.
  18. American College of Obstetricians and Gynecologists: ACOG Practice Bulletin No. 141. management of menopausal symptoms. Obstet Gynecol 2014; 123:202-216. DOI: https://doi.org/10.1097/01.AOG.0000441353.20693.78
  19. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017; 24(7):728-753. DOI: https://doi.org/10.1097/GME.0000000000000921
  20. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee JLong-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017; 1:CD004143. DOI:
  21. https://doi.org/10.1002/14651858.CD004143.pub5
  22. Espinosa DJ. Analytical review of multicenter studies with polycresulene for hemorrhoidal pathologies. Acta Gastroenterol Latinoam. 2000; 30(3):177-186.

Informações

Palavras-chave

Código QR

Sistema OJS 3.4.0.10 - Metabiblioteca |